<DOC>
	<DOCNO>NCT00223691</DOCNO>
	<brief_summary>The autonomic nervous system serve multiple regulatory function body , include regulation blood pressure heart rate , gut motility , sweat sexual function . There several disease characterize abnormal function autonomic nervous system . Medications also alter autonomic function . Impairment autonomic nervous system disease drug may lead several symptom , include blood pressure problem ( e.g. , high blood pressure lie low blood pressure stand ) , sweat abnormality , constipation diarrhea sexual dysfunction . Because treatment option patient limited . We propose study patient autonomic failure low blood pressure upon stand determine cause disease history examination response autonomic test already standardize laboratory . Based possible cause , test different medication may alleviate symptom .</brief_summary>
	<brief_title>Treatment Orthostatic Hypotension Autonomic Failure</brief_title>
	<detailed_description>Subjects admit Clinical Research Center Vanderbilt University study . The average inpatient stay 7 day . Initially complete history physical perform patient place low monamine , methylxanthine , 150 mEq sodium , 60-80 mEq potassium diet . The following test perform : 1 . Meal challenge : We observe profound effect diet blood pressure many patient orthostatic hypotension . Some patient drop blood pressure 40-60 mmHg postprandial period . Blood pressure monitor automated device ( Dinamap ) feed patient standardized diet . 2 . Physiologic autonomic test : Patients studied supine , blood pressure monitor sphygmomanometer automate device ( Dinamap , Finapres tonometer ) . 1 . Orthostatic test : Blood pressure heart rate measure supine stand position . Orthostatic hypotension without adequate heart rate increase indicative autonomic failure . On hand , orthostatic tachycardia absence volume depletion see `` hyperadrenergic orthostatic hypotension '' . 2 . Standing time : The time patient stand motionless give good indication functional capacity . 3 . Deep breathing : Heart rate monitor ECG patient ask breathe deeply 6 time minute two minute . Heart rate variation due respiration autonomic function . The loss respiratory arrhythmia indicative autonomic failure . 4 . Valsalva maneuver : The patient ask exhale 40 mmHg pressure . This produce transient change blood pressure heart rate autonomically mediate , monitor ECG . Failure observe heart rate change indicative autonomic failure . 5 . Hyperventilation : The patient ask hyperventilate 30 second . The normal response increase heart rate significant change blood pressure . Patients autonomic failure profound reduction blood pressure without compensatory heart rate increase . 6 . Handgrip : The patient ask maintain handgrip three minute . Increases heart rate blood pressure see normal subject patient autonomic failure . 7 . Cold pressor test : The patient ask place hand ice cold water one minute . The result similar handgrip test . 8 . Supine hypertension screening : We measure blood pressure every two hour one night determine patient supine hypertension high blood pressure lie . 3 . Posture Study : Blood catecholamine , bradykinins , plasma renin activity , aldosterone plasma angiotensin II drawn patient supine upright . Blood pressure measure sphygmomanometer automate device ( Dinamap ) . Normally , assume upright posture , plasma norepinephrine renin activity double . Patients autonomic failure typically show low supine level norepinephrine renin activity fail increase assume upright posture . In contrast , patient hyperadrenergic orthostatic hypotension typically normal exaggerated response . 4 . Twelve hour urine collection catecholamine , urinalysis , protein , glucose , creatinine , osmolality , electrolytes F2-isoprostanes collect analyze catecholamine excretion ( hormones produce autonomic nervous system ) oxidative stress marker assess patient 's kidney function . 5 . Blood collect fasted state intravenous catheter analyze PAI-1 , CRP , F2-isoprostanes , proinflammatory cytokine renal function . 6 . EKG record patient lie patient standing . 7 . Orthostatic vital sign measure several time day . This test consist blood pressure heart rate measure patient lying repeat stand quietly 10 minute . Several reading measure sequence use automate blood pressure monitor ( Dinamap ) . 8 . Tilt table test : This test use tilt table , motorize table footboard . The participant rest quietly table monitoring equipment assemble . EKG electrodes apply chest monitor heart rate rhythm . Blood pressure measure cuff apply finger . Blood pressure also check periodically use traditional blood pressure cuff wrap around upper arm . Safety strap use secure patient table prevent fall unsteadiness table move upright position . Gradual head tilt perform systolic blood pressure 70 mm Hg reach appearance symptom related hypotension . Changes cardiac output ( heart 's pumping capacity ) measure analyze air breathe ( `` rebreathing test '' , Innocor ) . This do mouthpiece connect bag full air small concentration inactive gas SF6 N2O . Subjects breathe normally mouthpiece connect bag 5 minute baseline , 30ยบ maximum head tilt . Innocor FDA approve inert gas cardiac output measurement . This test may may perform . Some patient may already undergo test may pertinent particular patient . The principal investigator decide whether test perform . 9 . Therapeutic Drug Trials : We try different medication determine blood pressure improve upon stand . For test , blood pressure monitor sphygmomanometer heart rate ECG . The procedure detail . Patients fast state seat position throughout study . They connect automate blood pressure monitor ( Dinamap ) . Thirty minute baseline blood pressure heart rate measurement , give dose medicine test . Blood pressure monitor every 5 15 minute four additional hour . Upright blood pressure , heart rate standing time measure periodically throughout study . The patient ask rate symptom various time study . This study design determine optimal candidate drug therapy treatment orthostatic hypotension . Potential pressor agent select study different mechanism action . We propose also use combination different therapeutic agent . For test , follow : 1. determine effect medication catecholamine and/or marker inflammation and/or oxidative stress . We draw blood sample baseline medication take effect . A saline lock small flexible intravenous catheter place purpose . For medication trial , amount blood drawn would 6 teaspoon . The total blood drawn medication trial would exceed 36 teaspoon . 2 . We apply external abdominal compression ( 40mm Hg ) evaluate ability counterpressure method combination pressor agent improve orthostatic tolerance . For purpose , use abdominal binder inflatable cuff place underneath , inflated exert pressure level umbilicus patient stand . Patients may randomly assign 5mm Hg ( sham treatment ) and/or 20-40mm Hg external abdominal compression abdominal binder apply baseline therapeutic trial describe . The principal investigator decide medication use trial . 3 . We measure change cardiac output ( heart 's pumping capacity ) analyze air breathe ( `` rebreathing test '' , Innocor ) . This do mouthpiece connect bag full air small concentration inactive gas SF6 N2O . Subjects breathe normally mouthpiece connect bag 5 minute medication . Innocor FDA approve inert gas cardiac output measurement . 4 . We measure cerebral blood flow determine improve medication . A middle cerebral artery continuously insonated transcranial Doppler ultrasonography . The transducer affixed head strap . 5 . We apply eleven sticky patch front body measure impedance ( electrical resistance ) . This allow u determine fluid shift body segment obtain continuous measurement cardiac output peripheral resistance .</detailed_description>
	<mesh_term>Hypotension</mesh_term>
	<mesh_term>Pure Autonomic Failure</mesh_term>
	<mesh_term>Hypotension , Orthostatic</mesh_term>
	<mesh_term>Diphenhydramine</mesh_term>
	<mesh_term>Promethazine</mesh_term>
	<mesh_term>Tranylcypromine</mesh_term>
	<mesh_term>Ranitidine bismuth citrate</mesh_term>
	<mesh_term>Octreotide</mesh_term>
	<mesh_term>Ranitidine</mesh_term>
	<mesh_term>Atomoxetine Hydrochloride</mesh_term>
	<mesh_term>Rivastigmine</mesh_term>
	<mesh_term>Carbidopa</mesh_term>
	<mesh_term>Ephedrine</mesh_term>
	<mesh_term>Pyridostigmine Bromide</mesh_term>
	<mesh_term>Yohimbine</mesh_term>
	<mesh_term>Carbidopa , levodopa drug combination</mesh_term>
	<mesh_term>Levodopa</mesh_term>
	<mesh_term>Caffeine</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<mesh_term>Ergotamine</mesh_term>
	<mesh_term>Midodrine</mesh_term>
	<mesh_term>Oxymetazoline</mesh_term>
	<mesh_term>Phenylephrine</mesh_term>
	<mesh_term>Indomethacin</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<mesh_term>Modafinil</mesh_term>
	<mesh_term>Armodafinil</mesh_term>
	<mesh_term>Acarbose</mesh_term>
	<mesh_term>Acetazolamide</mesh_term>
	<mesh_term>Bromides</mesh_term>
	<mesh_term>Pseudoephedrine</mesh_term>
	<criteria>Patients refer evaluation autonomic function Ages 1885 Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>orthostatic hypotension</keyword>
	<keyword>autonomic failure</keyword>
</DOC>